APA (7th ed.) Citation

LM, M., JB, K., SW, S., DW, M., MA, L., V, S., . . . JN, B. (2022). Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility. Gynecologic oncology, 165(3), 568. https://doi.org/10.1016/j.ygyno.2022.03.018

Chicago Style (17th ed.) Citation

LM, Marinelli, et al. "Methylated DNA Markers for Plasma Detection of Ovarian Cancer: Discovery, Validation, and Clinical Feasibility." Gynecologic Oncology 165, no. 3 (2022): 568. https://doi.org/10.1016/j.ygyno.2022.03.018.

MLA (9th ed.) Citation

LM, Marinelli, et al. "Methylated DNA Markers for Plasma Detection of Ovarian Cancer: Discovery, Validation, and Clinical Feasibility." Gynecologic Oncology, vol. 165, no. 3, 2022, p. 568, https://doi.org/10.1016/j.ygyno.2022.03.018.